XSES
O10
Market cap384mUSD
Oct 09, Last price
1.01SGD
1D
1.00%
1Q
-9.01%
Jan 2017
-32.21%
Name
Far East Orchard Ltd
Chart & performance
P/E
9.20
P/S
2.01
EPS
0.11
Div yield, %
5.00%
Shrs. gr., 5y
2.03%
Rev. gr., 5y
17.15%
Revenues
248m
+29.06%
Net income
54m
-8.41%
CFO
37m
-34.10%
Dividend
May 08, 20260.04 SGD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Far East Orchard Limited operates as an investment holding company, concentrating on hotel management and various property investments across Singapore, Australia, New Zealand, the United Kingdom, and other global regions. The company's primary focus involves developing diverse properties, including residential, commercial, hospitality, and specialized student accommodation projects. It also holds ownership and oversees the operation of hospitality assets, such as hotels. Additionally, its investment holdings encompass commercial office spaces at Tanglin Shopping Centre, as well as medical suites located in Novena Medical Center and Novena Specialist Center. The company further offers property management and leasing services. Founded in Singapore in 1967, it operated as Orchard Parade Holdings Limited before its rebranding to Far East Orchard Limited in July 2012. Far East Orchard Limited functions as a subsidiary of Far East Organization Pte. Ltd.
Key people
Non-Executive Chairman of the Board · since 2013
Yin Yin Gok
Chief Financial Officer · since 2018
Yew Kuen Tang
Group Chief Executive Officer, Executive Director · since 2020
Chong Foon Chwee
Company Secretary · since 2015
Phua Siyu
Company Secretary · since 2016
Kah Sek Koh
Non-Executive Director · since 2016
Ramlee Bin Buang
Non-Executive Independent Director · since 2017
Non-Executive Independent Director · since 2014
Choo Lin Ee
Non-Executive Independent Director · since 2011
Shailesh Anand Ganu
Non-Executive Independent Director · since 2019
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||